Inflammation biomarkers in blood as mortality predictors in community-acquired pneumonia admitted patients: Importance of comparison with neutrophil count percentage or neutrophil-lymphocyte ratio

Biomarkers for predicting short-term mortality in community-acquired pneumonia: A systematic review and meta-analysis

(2016) Diego Viasus et al.   JOURNAL OF INFECTION

Neutrophil­to­lymphocyte ratio: A novel and simple prognostic marker for infective endocarditis

(2015) Mehmet Bozbay et al.   JOURNAL OF CRITICAL CARE

Performance of pro-adrenomedullin for identifying adverse outcomes in community-acquired pneumonia

(2015) Pedro P. España et al.   JOURNAL OF INFECTION

Red blood cell distribution width [RDW] and long-term mortality after community-acquired pneumonia. A comparison with proadrenomedullin

(2015) S. Bello et al.   RESPIRATORY MEDICINE

Incidence, timing and risk factors associated with 1-year mortality after hospitalization for community-acquired pneumonia

(2014) Jordi Adamuz et al.   JOURNAL OF INFECTION

Community-Acquired Pneumonia

(2014) Richard G. Wunderink et al.   NEW ENGLAND JOURNAL OF MEDICINE

Midregional proadrenomedullin for prognosis in community-acquired pneumonia: A systematic review

(2014) Rodrigo Cavallazzi et al.   RESPIRATORY MEDICINE

The incidence of cardiovascular events after hospitalization due to CAP and their association with different inflammatory markers

(2014) Olga Rajas et al.   BMC Pulmonary Medicine

Proadrenomedullin, a useful tool for risk stratification in high Pneumonia Severity Index score community acquired pneumonia

(2012) Caroline Courtais et al.   AMERICAN JOURNAL OF EMERGENCY MEDICINE

The Neutrophil-Lymphocyte Count Ratio in Patients with Community-Acquired Pneumonia

(2012) Cornelis P. C. de Jager et al.   PLoS One

Copeptin predicts clinical deterioration and persistent instability in community-acquired pneumonia

(2012) M. Kolditz et al.   RESPIRATORY MEDICINE

Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: Derivation of a clinical algorithm

(2011) Werner C Albrich et al.   BMC INFECTIOUS DISEASES

Cardiovascular and Inflammatory Biomarkers to Predict Short- and Long-Term Survival in Community-acquired Pneumonia

(2010) Stefan Krüger et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Prognostic value of procalcitonin in community-acquired pneumonia

(2010) P. Schuetz et al.   EUROPEAN RESPIRATORY JOURNAL

Severity assessment tools for predicting mortality in hospitalised patients with community-acquired pneumonia. Systematic review and meta-analysis

(2010) J. D. Chalmers et al.   THORAX

Midregional Proadrenomedullin as a Prognostic Tool in Community-Acquired Pneumonia

(2009) David T. Huang et al.   CHEST

Prospective Comparison of Severity Scores for Predicting Clinically Relevant Outcomes for Patients Hospitalized With Community-Acquired Pneumonia

(2009) Pedro Pablo España Yandiola et al.   CHEST

Neutrophil/lymphocyte ratio and its association with survival after complete resection in non–small cell lung cancer

(2008) Khaled M. Sarraf et al.   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY

Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases

(2007) K.J. Halazun et al.   EJSO